Faster versus slower infusion times for a stomach cancer chemotherapy drug

This trial is testing whether the speed at which oxaliplatin (a chemotherapy drug) is infused into your vein affects how much nerve damage you experience during cancer treatment. Half of participants will receive the medication over 2 hours, and half will receive it over 6 hours on each treatment day. The main goal is to see if the faster infusion causes less nerve pain and tingling—a common and sometimes serious side effect of this chemotherapy.

Oxaliplatin can damage nerves in your hands and feet, sometimes making it hard to do daily activities. Researchers hope that changing how quickly the medication enters your bloodstream might reduce this side effect while keeping the treatment just as effective against cancer.